Skip to main content
. 2021 Apr 26;35:100863. doi: 10.1016/j.eclinm.2021.100863

Figure 7.

Figure 7

Age-stratified effect of the relative infectiousness of the asymptomatic population, with respect to the symptomatic population, on the average peak hospitalization and total number of deaths for a vaccine that does not prevent transmission but can reduce symptoms in case of inadequate primary response (I1-S0), assuming 50% efficacy, 50% coverage, 6-month durability, and early vaccination (on or before Month 2).